论文信息 - Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.

Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.

The anticholinesterase activity of a new carbamate, heptylphysostigmine, was studied in vitro. This compound is a competitive inhibitor of acetylcholinesterase (or true cholinesterase) having Ki = (1 +/- 0.5) X 10(-7) M. The inhibition was instantaneous at the onset and did not diminish with prolonged incubation of the drug and enzyme.

[1] E. Albuquerque,et al. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. , 1985, Molecular pharmacology.

[2] D. Burk,et al. The Determination of Enzyme Dissociation Constants , 1934 .

[3] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[4] K. Davis,et al. Physostigmine: improvement of long-term memory processes in normal humans. , 1978, Science.

[5] M. Dixon. The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[6] H. Fibiger,et al. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: Reversal by physostigmine , 1985, Neuroscience.

[7] A. Cornish-Bowden. Fundamentals of Enzyme Kinetics , 1979 .

[8] R. Whelpton,et al. PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES , 1985, The Lancet.